ALDX
Aldeyra Therapeutics, Inc.
1.30$
-3.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +2.3% | -8.8% | +1.6% | +2.2% | +2.2% | -5.4% | +2.2% | +2.2% | +2.2% | +2.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -38.3% | +43.9% | +142.1% | -16.9% | +17.6% | -49.3% | +14.6% | -36.1% | -20.8% | -44.0% | +44.6% | – | |
| – | -30.5% | +78.4% | -5.4% | +21.7% | -47.3% | +54.2% | -44.6% | +54.5% | -8.0% | +48,103,998.5% | -100.0% | – | |
| – | -36.2% | +54.1% | +91.7% | -10.4% | +2.7% | -37.1% | -2.5% | -21.3% | -16.7% | -47.8% | +68.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.5% | -3.1% | -4.2% | +0.3% | -1.8% | +2.7% | -2.7% | +1.1% | -0.1% | -1.4% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -262.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.